The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
A Novel Hydrogen Sulfide Prodrug, SG 1002, Promotes Hydrogen Sulfide and Nitric Oxide Bioavailability in Heart Failure Patients
Open accessAbstract
Summary: Recent studies demonstrate robust molecular cross talk and signaling between hydrogen sulfide (H 2 S) and nitric oxide (NO). Heart failure (HF) patients are deficient in both H 2 S and NO, two molecules that are critical for cardiovascular homeostasis. A phase I clinical trial of a novel H 2 S prodrug (SG 1002) was designed to assess safety and changes in H 2 S and NO bioavailability in healthy and HF subjects. Healthy subjects (n = 7) and heart failure patients (n = 8) received oral SG 1002 treatment in escalating dosages of 200, 400, and 800 mg twice daily for 7 days for each dose. Safety and tolerability were assessed by physical examination, vital signs, and ECG analysis. Plasma samples were collected during a 24‐h period each week for H 2 S and NO analysis. BNP and glutathione levels were analyzed as markers of cardiac health and redox status. Administration of SG 1002 resulted in increased H 2 S levels in healthy subjects. We also observed increased H 2 S levels in HF subjects following 400 mg SG 1002. Nitrite, a metabolite of NO, was increased in both healthy and HF patients receiving 400 mg and 800 mg SG 1002. HF subjects treated with SG 1002 displayed stable drug levels over the course of the trial. SG 1002 was safe and well tolerated at all doses in both healthy and HF subjects. These data suggest that SG 1002 increases blood H 2 S levels and circulating NO bioavailability. The finding that SG 1002 attenuates increases in BNP in HF patients suggests that this novel agent warrants further study in a larger clinical study.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress
Cai, H., & Harrison, D. G. (2000) · Circulation Research · doi:10.1161/01.res.87.10.840 · Cited by 3,839
Wink, D. A., & Mitchell, J. B. (1998) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(98)00092-6 · Cited by 1,606
Interactions of Peroxynitrite, Tetrahydrobiopterin, Ascorbic Acid, and Thiols
Kuzkaya, N., Weissmann, N., Harrison, D. G., & Dikalov, S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302227200 · Cited by 692
Nitric oxide as an antioxidant
Kanner, J., Harel, S., & Rina, G. (1991) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(91)90452-o · Cited by 429
Wang, Y., Zhao, X., Jin, H., Wei, H., Li, W., Bu, D., Tang, X., Ren, Y., Tang, C., & Du, J. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.179333 · Cited by 307
Hydrogen sulfide enhances ulcer healing in rats
Wallace, J. L., Dicay, M., McKnight, W., & Martin, G. R. (2007) · The FASEB Journal · doi:10.1096/fj.07-8669com · Cited by 236
Anti-Inflammatory and Cytoprotective Actions of Hydrogen Sulfide: Translation to Therapeutics
Wallace, J. L., Blackler, R. W., Chan, M. V., Da Silva, G. J., Elsheikh, W., Flannigan, K. L., Gamaniek, I., Manko, A., Wang, L., Motta, J.-P., et al. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2014.5901 · Cited by 156
Bhushan, S., Kondo, K., Polhemus, D. J., Otsuka, H., Nicholson, C. K., Tao, Y.-X., Huang, H., Georgiopoulou, V. V., Murohara, T., Calvert, J. W., et al. (2014) · Circulation Research · doi:10.1161/circresaha.114.301475 · Cited by 69
Self-citationSingle-Dose Pharmacokinetics of Different Oral Sodium Nitrite Formulations in Diabetes Patients
Greenway, F. L., Predmore, B. L., Flanagan, D. R., Giordano, T., Qiu, Y., Brandon, A., Lefer, D. J., Patel, R. P., & Kevil, C. G. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0291 · Cited by 43
Self-citation
Cited by
Nitric oxide signalling in cardiovascular health and disease
Farah, C., Michel, L. Y. M., & Balligand, J.-L. (2018) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.224 · Cited by 779
Physiological roles of hydrogen sulfide in mammalian cells, tissues, and organs
Cirino, G., Szabo, C., & Papapetropoulos, A. (2023) · Physiological Reviews · doi:10.1152/physrev.00028.2021 · Cited by 553
Szabo, C., & Papapetropoulos, A. (2017) · Pharmacological Reviews · doi:10.1124/pr.117.014050 · Cited by 423
Cao, X., Ding, L., Xie, Z.-Z., Yang, Y., Whiteman, M., Moore, P. K., & Bian, J.-S. (2019) · Antioxidants & Redox Signaling · doi:10.1089/ars.2017.7058 · Cited by 408
Hydrogen sulfide: An endogenous regulator of the immune system
Dilek, N., Papapetropoulos, A., Toliver-Kinsky, T., & Szabo, C. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105119 · Cited by 292
Metadata
- Authors
- Polhemus, D. J., Li, Z., Pattillo, C. B., Gojon, G., Gojon, G., Giordano, T., & Krum, H.
- Venue
- Cardiovascular Therapeutics
- Publisher
- Wiley
- Published
- 2015-07-07
- Volume
- 33
- Issue
- 4
- Pages
- 216-226
- ISSN
- 1755-5914 (ISSN-L)
- 1755-5922
- OpenAlex
- W2009296914
- Cited by
- 169
- References
- 9
- FWCI
- 5.17
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Novel Hydrogen Sulfide Prodrug, SG 1002, Promotes Hydrogen Sulfide and Nitric Oxide Bioavailability in Heart Failure Patients. https://app.cochat.ai/papers/10.1111/1755-5922.12128
- The paper
- Polhemus, D. J., Li, Z., Pattillo, C. B., Gojon, G., Gojon, G., Giordano, T., & Krum, H. (2015). A Novel Hydrogen Sulfide Prodrug, SG 1002, Promotes Hydrogen Sulfide and Nitric Oxide Bioavailability in Heart Failure Patients. Cardiovascular Therapeutics. https://doi.org/10.1111/1755-5922.12128
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.